Fox, James M <br/><br/>
CCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cells.  [electronic resource] 

 -  Journal of leukocyte biology  Jul 2015 
 - 59-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1938-3673 
<br/><br/><label>Standard No.: </label>10.1189/jlb.2A0414-193RR  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Antigens--blood<br/>CHO Cells<br/>Cricetinae<br/>Cricetulus<br/>Down-Regulation<br/>Humans<br/>Ligands<br/>Microscopy, Fluorescence<br/>Myeloid Cells--metabolism<br/>Protein Conformation<br/>Receptors, CCR5--immunology<br/>T-Lymphocytes--metabolism